A novel central nervous system embryonal tumor successfully treated with multi‐modal therapy highlights limitation of methylation‐based tumor classification-Reference-Cited by-同舟云学术

A novel central nervous system embryonal tumor successfully treated with multi‐modal therapy highlights limitation of methylation‐based tumor classification

Published:2021-12-16 Issue: Volume: Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Lamichhane Ritu¹,Roy Paromita²,Hawkins Cynthia³⁴,Zameer Lateef²,Gehani Anisha⁵,Achari Rimpa B.⁶,Ho Ben⁴,Huang Annie⁴⁷,Tabori Uri⁴⁷,Ramaswamy Vijay⁴⁷^ORCID,Sukumaran Reghu K.¹,Das Anirban¹⁴⁷^ORCID

Affiliation:

1. Department of Paediatric Haematology Oncology Tata Medical Center Kolkata India

2. Department of Pathology Tata Medical Center Kolkata India

3. Department of Paediatric Laboratory Medicine Hospital for Sick Children Toronto Canada

4. The Arthur and Sonia Labatt Brain Tumour Research Centre Hospital for Sick Children Toronto Canada

5. Department of Radiology Tata Medical Center Kolkata India

6. Department of Radiation Oncology Tata Medical Center Kolkata India

7. Division of Haematology Oncology Department of Paediatrics Hospital for Sick Children Toronto Canada

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29520

Reference11 articles.

1. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

2. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

3. Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas

4. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes

5. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation